Canadian Gold Corp. (TSXV:CGC)
Canada · Delayed Price · Currency is CAD | Market Cap | 126.35M +333.6% |
| Revenue (ttm) | n/a |
| Net Income | -3.83M |
| EPS | -0.02 |
| Shares Out | 210.58M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 243,658 |
| Open | 0.6100 |
| Previous Close | 0.6400 |
| Day's Range | 0.6000 - 0.6100 |
| 52-Week Range | 0.1500 - 0.7700 |
| Beta | 0.56 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 28, 2026 |
About Canadian Gold
As of January 5, 2026, Canadian Gold Corp. was acquired by McEwen Inc. Canadian Gold Corp. explores and develops mineral properties in Canada. Its principal project is the Tartan Lake gold mine project that consists of 20 mineral claims covering an area of approximately 2,670 hectares located northeast of the town of Flin Flon, Manitoba, Canada. The company was formerly known as Satori Resources Inc. and changed its name to Canadian Gold Corp. in May 2023. Canadian Gold Corp. was incorporated in 2011 and is based in Toronto, Canada. [Read more]
Financial Performance
Financial StatementsNews
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now
When a company restates its earnings, it often indicates mistakes were made, which can be a troubling issue for a penny stock.
Should You Buy CGC Stock After Marijuana Reclassification?
Canopy Growth gains attention as marijuana reclassification boosts cannabis sentiment, but margin pressure and execution risks persist.
Canopy Growth's Stock Just Dropped -- Here's Why I'm Still Not Buying
It's unfitting that the marijuana seller has "growth" in its name.
Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) expects to release its financial results for the quarter and fiscal year ...
Is Canopy Growth Stock Finally Setting Up for a Real Turnaround?
The cannabis company has reduced debt and stacked up cash, but profitability remains elusive.
Canadian Marijuana Stocks Showing Strong Momentum in May
Canadian cannabis stocks remain active in May 2026. Investors continue watching the sector for growth opportunities and reform catalysts. In addition, many traders expect future federal progress in th...
Canopy Growth Is One of the Market's Most Polarizing Stocks: 3 Scenarios for the Next 12 Months
After years of heavy losses and repeated restructurings, Canopy Growth is showing early signs of stabilization.
Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) and Spectrum Therapeutics today announced an expansion of its Minor Canna...
3 Canadian Marijuana Stocks That Could Benefit From U.S. Reform
The Canadian cannabis sector continues to evolve as investors look for the next major catalyst. Recently, optimism has increased around potential U.S. cannabis reform. As a result, many Canadian compa...
Canopy Growth Stock Is Jumping. Is It Overdue for a Much Bigger Rally?
The pot stock is up over 30% in just the past month.
Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce?
Canopy Growth shares are up 25% over the past month, but investors need to keep in mind where it started.
'GIANT STEP FORWARD': Reclassification of medical cannabis lauded
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.' 00:00 Introduction & Re...
Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change
Akanda Corp. (NASDAQ: AKAN) shares continued to surge today after U.S. regulators moved to reclassify certain marijuana products, fueling a broader rally in cannabis stocks. • Akanda stock is chargin...
'Big Business Opportunity': Cannabis CEO Celebrates DOJ Easing Regulations On Medical Marijuana
The Trump administration reclassified medical marijuana as a less dangerous drug on Thursday. FDA-approved and state-licensed medical marijuana was rescheduled from a Schedule I drug to the less stric...
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling Food and Drug Administration-approved and state-licensed medical cannabis products as a...
Cannabis Stocks Soared—Than Sank. Here's What Investors Need to Know.
Marijuana-related investments were flying high this morning. Then they reversed course, and quickly.
Cannabis rescheduling fuels optimism across industry
The U.S. Department of Justice is immediately loosening restrictions on some marijuana products and accelerating the process of reclassifying the drug as less dangerous in one of the biggest changes t...
What's Going On With Canopy Growth Stock Thursday?
Canopy Growth Corp (NASDAQ:CGC) shares are falling Thursday, pulling back after Wednesday's rally on U.S. cannabis policy shift. ... Full story available on Benzinga.com
Canopy Growth (CGC) Shares Surge on Rescheduling of Medical Marijuana
Canopy Growth (CGC) Shares Surge on Rescheduling of Medical Marijuana
‘There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign
SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “Canopy” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced a refresh of Tweed, one of Canada's most recogni...
Akanda (AKAN) Stock Continues Soaring Overnight Amid Trump Cannabis Reclassification Report: What You Should Know
Akanda Corp. (NASDAQ: AKAN) shares are trending on Thursday. AKAN shares climbed 33.69% to $13.65 after the bell on Wednesday. The after-hours gain follows a 214.15% surge during the regular session,...
Trump's Marijuana Reclassification Plan Sparks Cannabis ETF Rally—Is A Breakout Finally Here?
Cannabis ETFs surged Wednesday after Axios reported that the Donald Trump administration is set to reclassify marijuana as a Schedule III drug as soon as today. The rally was seen across the cannabis ...
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe cou...
Canopy Growth Stock Surges On Impending Trump Administration Marijuana Reclassification: Report
Shares of Canopy Growth (NASDAQ: CGC) are surging Wednesday afternoon following news of a potential major shift in federal cannabis policy. ... Full story available on Benzinga.com
Canopy Growth Stock Surges On Impending Trump Administration Marijuana Reclassification: Report
Shares of Canopy Growth Corp (NASDAQ:CGC) are trading sharply higher Wednesday afternoon following news of a potential major shift in federal cannabis policy. Here's what investors need to know.